UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): February 16, 2012
PSS WORLD MEDICAL, INC.
(Exact name of Registrant as specified in its charter)
Commission File Number: 0-23832
| Florida | 59-2280364 |
| (State or other jurisdiction | (IRS Employer |
| of incorporation or organization) | Identification Number) |
| 4345 Southpoint Blvd. | |
| Jacksonville, Florida | 32216 |
| (Address of principal executive offices) | (Zip code) |
| Registrant’s telephone number, including area code | (904) 332-3000 |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
| o | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| o | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| o | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| o | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 8.01. Other Events.
On February 16, 2012, PSS World Medical, Inc. issued a press release announcing the pricing of its private offering of $250 million aggregate principal amount of 6.375% senior notes due 2022. The notes are being offered inside the United States to qualified institutional buyers in reliance on Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”), and outside the United States to non-U.S. persons in reliance on Regulation S under the Securities Act.
A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference. The press release does not constitute an offer to sell or the solicitation of an offer to buy the notes. The notes have not been registered under the Securities Act or applicable state securities laws and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the Securities Act and applicable state laws.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits
| Exhibit | ||
| Number | Description | |
| 99.1 | Press release dated February 16, 2012. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| PSS WORLD MEDICAL, INC. | ||||
Date: February 16, 2012 | By: | /s/ | David M. Bronson | |
| Name: | David M. Bronson | |||
| Title: | Executive Vice President and Chief Financial Officer | |||
| Exhibit | ||
| Number | Description | |
| 99.1 | Press release dated February 16, 2012. |